Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chan

Showing results (1061-1070 of 1,535) with videos related to

Pageof 154
Sort By:
Ambio|February 26, 2013
The challenges of incorporating cultural ecosystem services into environmental assessmentDebra Satz, Rachelle K Gould, Kai M A Chan, et al.
JCI Insight|October 26, 2016
The head and neck cancer immune landscape and its immunotherapeutic implicationsRajarsi Mandal, Yasin Şenbabaoğlu, Alexis Desrichard, et al.
Plos Medicine|May 30, 2008
Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosisTimothy A Chan, Sabine Glockner, Joo Mi Yi, et al.
BMC Health Services Research|September 5, 2024
Perspectives on a peer-driven intervention to promote pre-exposure prophylaxis (PrEP) uptake among men who have sex with men in southern New England: a qualitative studyJun Tao, Hannah Parent, Ishu Karki, et al.
Journal of the International AIDS Society|August 20, 2019
Long-term retention in pre-exposure prophylaxis care among men who have sex with men and transgender women in the United StatesPhilip A Chan, Rupa R Patel, Leandro Mena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2006
Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage?R Leonard, J O'Shaughnessy, S Vukelja, et al.
The Lancet. Oncology|May 10, 2015
Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 studyAlexandria T Phan, Daniel M Halperin, Jennifer A Chan, et al.
BMC Cancer|April 14, 2018
Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapyKim A Brogden, Deepak Parashar, Andrea R Hallier, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2014
Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgeryT Jonathan Yang, Jung Hun Oh, Michael R Folkert, et al.
Cardiovascular Drugs and Therapy|August 5, 2014
Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetesCher-Rin Chong, Wai Ping A Chan, Thanh H Nguyen, et al.
Pageof 154

Showing results (1061-1070 of 1,535) with videos related to

Sort By:
Pageof 154
Ambio|February 26, 2013
The challenges of incorporating cultural ecosystem services into environmental assessmentDebra Satz, Rachelle K Gould, Kai M A Chan, et al.
JCI Insight|October 26, 2016
The head and neck cancer immune landscape and its immunotherapeutic implicationsRajarsi Mandal, Yasin Şenbabaoğlu, Alexis Desrichard, et al.
Plos Medicine|May 30, 2008
Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosisTimothy A Chan, Sabine Glockner, Joo Mi Yi, et al.
BMC Health Services Research|September 5, 2024
Perspectives on a peer-driven intervention to promote pre-exposure prophylaxis (PrEP) uptake among men who have sex with men in southern New England: a qualitative studyJun Tao, Hannah Parent, Ishu Karki, et al.
Journal of the International AIDS Society|August 20, 2019
Long-term retention in pre-exposure prophylaxis care among men who have sex with men and transgender women in the United StatesPhilip A Chan, Rupa R Patel, Leandro Mena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2006
Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage?R Leonard, J O'Shaughnessy, S Vukelja, et al.
The Lancet. Oncology|May 10, 2015
Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 studyAlexandria T Phan, Daniel M Halperin, Jennifer A Chan, et al.
BMC Cancer|April 14, 2018
Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapyKim A Brogden, Deepak Parashar, Andrea R Hallier, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2014
Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgeryT Jonathan Yang, Jung Hun Oh, Michael R Folkert, et al.
Cardiovascular Drugs and Therapy|August 5, 2014
Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetesCher-Rin Chong, Wai Ping A Chan, Thanh H Nguyen, et al.
Pageof 154